Luca Iaccarino
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 130 publications
Performance of the Line Blot Immunoassay for Detecting Myositis Autoantibodies in Real-Life Laboratory Settings: An Italian Multicenter Study.
Journal: Annals of laboratory medicine
Published: January 09, 2026
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort.
Journal: Lupus science & medicine
Published: December 18, 2025
Evolving Therapeutic Strategies in ANCA-Associated Vasculitis: Current Standards and Emerging Targets for GPA and MPA.
Journal: Clinical reviews in allergy & immunology
Published: December 04, 2025
Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study.
Journal: Rheumatology (Oxford, England)
Published: November 30, 2025
Efficacy of anifrolumab on skin, joint and lung involvement in anti-MDA5 positive dermatomyositis: a case report.
Journal: Frontiers in immunology
Published: October 02, 2025
Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.
Journal: Rheumatology (Oxford, England)
Published: September 13, 2025
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.
Journal: The Lancet. Rheumatology
Published: July 26, 2025
Administration of belimumab prior to standard immunosuppression in patients with early active lupus hinders accrual of new EULAR/ACR criteria within the first 12 months of treatment.
Journal: Lupus science & medicine
Published: May 07, 2025
Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0).
Journal: Biologics : targets & therapy
Published: April 25, 2025
Patients with anti-SAE+ dermatomyositis display refractory and difficult-to-treat skin manifestations: case series from two Italian cohorts and review of literature.
Journal: Frontiers in immunology
Published: April 10, 2025
Unsupervised machine learning identifies distinct SLE patient endotypes with differential response to belimumab.
Journal: Rheumatology (Oxford, England)
Published: December 09, 2024
Last Updated: 09/26/2026